Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats for wound healing by Liu, Xiaoli et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 28, 2019
Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous
mats for wound healing
Liu, Xiaoli; Nielsen, Line Hagner; Klodzinska, Sylvia Natalie; Nielsen, Hanne Mørck; Qu, Haiyan;
Christensen, Lars Porskjær; Rantanen, Jukka; Yang, Mingshi
Published in:
European Journal of Pharmaceutics and Biopharmaceutics
Link to article, DOI:
10.1016/j.ejpb.2017.11.004
Publication date:
2017
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
Liu, X., Nielsen, L. H., Klodzinska, S. N., Nielsen, H. M., Qu, H., Christensen, L. P., ... Yang, M. (2017).
Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats for wound healing.
European Journal of Pharmaceutics and Biopharmaceutics, 123, 42-49. DOI: 10.1016/j.ejpb.2017.11.004
Accepted Manuscript
Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun
fibrous mats for wound healing
Xiaoli Liu, Line Hagner Nielsen, Sylvia Natalie Klodzinska, Hanne Mørck
Nielsen, Haiyan Qu, Lars Porskjær Christensen, Jukka Rantanen, Mingshi Yang
PII: S0939-6411(17)30417-4
DOI: https://doi.org/10.1016/j.ejpb.2017.11.004
Reference: EJPB 12628
To appear in: European Journal of Pharmaceutics and Biophar-
maceutics
Received Date: 31 March 2017
Revised Date: 30 October 2017
Accepted Date: 6 November 2017
Please cite this article as: X. Liu, L.H. Nielsen, S.N. Klodzinska, H.M. Nielsen, H. Qu, L.P. Christensen, J. Rantanen,
M. Yang, Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats for wound
healing, European Journal of Pharmaceutics and Biopharmaceutics (2017), doi: https://doi.org/10.1016/j.ejpb.
2017.11.004
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats 
for wound healing  
Xiaoli Liu
1
, Line Hagner Nielsen
2
, Sylvia Natalie Klodzinska
1
, Hanne Mørck Nielsen
1
, Haiyan Qu
3
, 
Lars Porskjær Christensen
3
, Jukka Rantanen
1
, Mingshi Yang
1,4,A
 
1
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, 
Denmark; 
2
Department of Micro- and Nanotechnology, Technical University of Denmark, Ørsteds 
Plads, Building 345C, DK-2800 Kongens Lyngby, Denmark; 
3
Department of Chemical Engineering, 
Biotechnology and Environmental Technology, University of Southern Denmark, Campusvej 55, 
DK-5230 Odense M, Denmark; 
4
Wuya College of Innovation, Shenyang Pharmaceutical University, 
Wenhua Road No. 103, 110016 Shenyang, China  
A
Corresponding author: Mingshi Yang(mingshi.yang@sund.ku.dk) 
 
 
 
  
  
Abstract 
Wound dressings should ideally be able to maintain high humidity, remove excess wound exudate, 
permit thermal insulation, provide certain mechanical strength, and in some cases deliver antibiotics 
to prevent infections. Until now, none of the existing wound dressing products can meet all these 
requirements. To design a wound dressing with as many of the aforementioned features as possible, 
in this study, we attempted to prepare ciprofloxacin (CIP), an antibiotic, loaded electrospun 
hydrophobic poly (lactic-co-glycolic acid) (PLGA) fibrous mats modified with hydrophilic sodium 
alginate (ALG) microparticles. The results showed that ALG could improve the wettability, water 
absorption capacity, and enhance the release rate of ciprofloxacin from the PLGA fibrous mats. In 
addition, the addition of ALG reduced the stiffness of PLGA fibrous mats for better protection of 
the injured area as indicated by the Young’s Modulus. Moreover, the burst release of CIP resulted 
from the addition of ALG seemed to provide an improved antibacterial effect to the PLGA mats . 
This study demonstrated the potential of combining hydrophilic and hydrophobic polymers to 
design the desired wound dressings via the electrospinning process. 
 
Key words: electrospinning; hydrodynamic methods; hydrophilicity; mechanical properties; 
antimicrobial activity; water-solid interactions  
 
  
  
1. Introduction 
Wound healing is a complex process beginning with haemostasis, inflammation, and removal of 
damaged matrix components, followed by tissue formation and remodeling[1]. Generally, 
inflammation occurs immediately after tissue damage, and new tissue formation occurs 2-10 days 
after injury with cellular proliferation and migration of different cell types to the site of injury. 
Remodeling is the final stage of wound healing, beginning 2-3 weeks after injury and continuing for 
a year or more. Healing of chronic wounds normally takes more than 12 weeks and often the 
wounds reoccur[2]. Chronic wounds are often heavily contaminated and usually involve significant 
tissue loss affecting vital structures of bones, joints, and nerves. Such wounds fail to heal due to 
repeated trauma to the injured area, and moreover physiological conditions such as diabetes, 
persistent infections, and poor primary treatment can also affect the healing[3]. Furthermore, 
impaired wound healing can lead to an excessive production of exudates causing maceration of the 
healthy skin tissue around the wound[4]. 
For better wound healing, a non-toxic and non-adherent wound dressing should be utilized. It 
should perform as a protective barrier, but also aid healing of the wound by fulfilling an array of 
requirements such as maintaining high humidity, removing excess wound exudates, and permitting 
thermal insulation. Further, it is beneficial if the dressing can allow for gas exchange, conforming to 
the wound surface and also be impermeable to bacteria[5-7]. However, none of the currently used 
wound dressing can fulfil all these reqirements. The majority of applied wound dressings can be 
classified as hydrocolloids, hydrogels, foams, or films[6, 8, 9]. Hydrocolloids and hydrogels can 
maintain moist wound environments and are usually used together with other functional layers. 
However, for the hydrocolloid wound dressings, the excessively moist environment caused by 
absorbing wound fluids might accelerate autolysis of necrotic tissue and increase the risk of 
infection[10]. In contrast, the hydrogels can swell or shrink in a reversible way, depending on the 
pH and ionic strength of the aqueous environment. This kind of wound dressing is more efficient 
when used for wounds with few exudates[8]. Foam-type dressings are also used for moderate/high 
draining wounds due to their high absorbance capacity, whereas films are normally durable, semi-
permeable, and impermeable to liquid and bacterial contamination[11]. However, medicated wound 
dressings based on films, which are characterized by incorporating an active agent in the films, do 
not have the capacity to absorb exudates[12]. To incorporate as many of the above-mentioned 
requirements as possible, new design of wound dressings are therefore desperately needed, and 
ideally they should be produced with an easy operating process. 
Nanofibrous mats produced by electrospinning have been reported to be good candidates for wound 
healing due to their unique properties, e.g. mimicking the biostructure of the extracellular matrix 
with high porosity aiding in exchanging of liquid and gases with the environment[13-15]. 
Electrospun fibrous mats (EFMs) possess small pores, which can protect the wound from bacterial 
penetration via aerosol particle capturing mechanisms[16]. In addition, therapeutic agents such as 
antimicrobials can be incorporated into the EFMs and thereby provide protection of the wound from 
contamination.  
  
Numerous natural polymers can be electrospun into fibrous mats for wound dressings, they are in 
general biocompatible and biodegradable, and moreover, have great similarity to the extracellular 
matrix. In previous studies, materials such as silk[17] and collagen[18] have been elecrospun into 
nanofibrous mats for wound healing. However, natural polymers exhibit a large variation in 
physicochemical characteristics due to the fact that they are materials derived from animals and 
plants from different sources and forms [19], and in addition some natural polymers cannot be 
electrospun into fibers owing to a few reasons such as high viscosity associated with their high 
molecular weight, degradation in solution, and difficulty to dissolve in adequate solvents[20, 21]. 
Furthermore, nanofibers prepared from most natural polymers lack the desired mechanical 
properties with regards to less than 10% elongation at break[22]. In contrast to natural polymers, 
synthetic polymers have more diverse physicochemical properties, including some being 
hydrophilic and others hydrophobic, good mechanical properties, and they are often also cheap, 
show little batch to batch variations and a higher degree of purity[21, 23]. The disadvantage of 
synthetic polymers is that they lack the biochemical signatures expressed in native fibers of the 
body. In order to form suitable and biomimetic nanofibers, natural and synthetic polymers may be 
combined.  
In this study, poly (lactic-co-glycolic acid) (PLGA) and sodium alginate (ALG) were combined and 
processed by using electrospinning to obtain nanofibrous mats with desired physicochemical 
properties for wound healing. ALG is one of the most studied and applied polysaccharides in wound 
healing, due to not only its abundance in nature, and its high water uptake potential[24] and PLGA 
was chosen because it is a biocompatible and biodegradable synthetic polymer, approved by FDA 
for a wide pharmaceutical application. Ciprofloxacin (CIP) was incorporated into the nanofibrous 
mats as a model antibiotic, and the resulting EFMs were characterized in vitro for their 
physicochemical properties and their antimicrobial activity.  
 
2. Materials and Methods 
2.1 Materials  
PLGA (lactic acid (LA): glycolic acid (GA), 75:25, molar ratio) with inherent viscosity (25°C, 0.1% 
chloroform) in the range 0.8-1.2 dl/g (RG750, MW 120,000-190,000 g/mol) was purchased from 
Evonik industries (Darmstadt, Germany). Trifluoroethanol, Mueller-Hinton broth, tryptic soy agar 
and chloroform were obtained from Sigma-Aldrich (Brøndby, Denmark) together with 
ciprofloxacin (CIP), sodium alginate (ALG) and phosphate buffered saline (PBS) tablets. 
UltraCruz
®
 Petri Dishes sc-351865, 100 mm × 15 mm were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA), and Staphylococcus aureus-15981 WT was kindly provided 
by the Institute of Immunology and Microbiology, University of Copenhagen, Denmark. Deionised 
water was obtained from an SG Ultra Clear water system (SG Water USA, Nashua, NH, USA) and 
was freshly produced in all cases. 
 
2.2 ALG particles preparation by spray drying 
ALG particles were prepared using a Büchi B-290 mini spray dryer (Buchi Labortechnik, Falvil, 
Switzerland) equipped with an inert loop B-295 (Buchi Labortechnik). 0.5 % (w/v) of ALG solution 
  
in water was prepared by spray drying at 170 ºC of inlet temperature resulting in an outlet 
temperature of approximately 90 ºC. The drying air flow rate was kept at 35 m
3
/h with an atomizing 
air flow rate of 667 L/h and feed flow rate of 2 mL/min. 
 
2.3 Preparation of electrospun fibrous mats (EFMs) 
25% (w/v) of PLGA was dissolved in a binary mixture of trifluoroethanol and chloroform (4:1 v/v), 
and left overnight to dissolve. Electrospinning was conducted at room temperature using a syringe 
pump (Harvard Apparatus, Quebec, Canada) and a 16 gauge needle (inner diameter 1.19 mm and 
outer diameter 1.65 mm) in a high-voltage supply (20 kV, max.) (Glassman High Voltage, High 
Bridge, NJ, USA). The flow rate was 10 μL/min, and the distance between the nozzle tip to the 
grounded collector was 10 cm. The fibers were collected on a stationary plate, and the voltage was 
adjusted to get a stable cone-jet with minimum change. In order to get homogenous mats for tensile 
strength test, a rotating drum (1500 rpm) was used to collect the electrospun samples.  
For preparation of CIP-loaded EFMs, CIP was dissolved in trifluoroethanol, while ALG particles 
were re-suspended in chloroform. Subsequently, the solution and suspension were added to the 
PLGA solution (prepared as described above). The drug loading was approximately 1 % (w/w) 
relative to the PLGA mass ratio, and the amount of ALG in the EFMs was varied to be either 1:100, 
2.5:100, and 4:100 (ALG:PLGA, w/w).  
 
2.4 Morphology of the EFMs 
The morphology of the EFMs was characterized using scanning electron microscope (SEM, Hitachi 
High-Tech HITACHI, Tokyo, Japan). The EFMs were mounted on metal stubs using double-sided 
adhesive tape and the samples were coated under vacuum with gold in an argon atmosphere prior to 
examination followed by imaging at an accelerating voltage of 5 kV. The diameter of electrospun 
fibers was determined by measuring the geometry of around 100 individual fibers from the SEM 
images using the instrument software (TM3030). 
 
2.5 Water contact angle 
For evaluation of the influence of ALG on the hydrophilicity of the PLGA EFMs, the water contact 
angle was measured using a drop shape analyzer (Mode: DSA100, KRÜSS, Hamburg, Germany). 
One droplet of water (20 µL) was added on the EFMs, and images of the water droplet were 
acquired at 0 min, after 30 min and after 2 h to observe the change of water contact angle over time. 
Each specimen was tested in triplicate. 
 
2.6 Water uptake - swelling of the EFMs  
The PLGA and ALG/PLGA EFMs were cut into 50 mm × 40 mm squares for assessment of the 
swelling properties of the fibers. The study was performed as a PBS absorption study. In brief; pre-
weighed EFMs (approximately 50 mg) were placed in 50 mL centrifuge tubes containing 40 mL of 
PBS at pH 7.4, and incubated at 37.0 ± 0.1 ºC for 4 h. All the samples were tested in triplicate. The 
wet weight of the samples was determined by weighing immediately after dehydrating the samples 
with filter paper to absorb water present at the fiber film surface after removal from PBS. The water 
uptake of the EFMs in PBS was then calculated using Eq. 1 and refered to as swelling (%):  
  
 
                                           Swelling (%) = ((w1- w0)/w0) × 100%                                         (Eq.1)  
where w0 and w1 are the weights of the EFMs before and after immersing in the PBS, respectively.  
 
2.7 Water sorption/desorption  
Water sorption/desorption studies of the EFMs were performed using a VTI Vapor Sorption 
Analyzer (SGA-100, VTI Corporation, Hialeah, FL, USA). The water sorption/ desorption profile 
was measured at 25 ºC and 60 ºC. The EFMs were dried at 60 ºC and close to 0 % relative humidity 
(RH), weighed and then weighed after increasing the RH in 10 % steps from approximately 0 % to 
90 % RH at 25 ºC. Equilibrium was assumed when the weight change was < 0.01% over a period of 
7 min. Each specimen was measured in triplicate. 
 
2.8 Tensile strength 
The tensile strength measurements were carried out utilizing a TA.XT plus texture analyzer (Stable 
Micro Systems, Godalming, UK) using the method described in a previous study[25]. The EFMs 
were cut into quadrangles of 5 cm × 1 cm, and the thickness of the mats was measured by an 
electronic micrometer (Schut Geometrical Metrology, Groningen, Netherland). In order to avoid 
breakage of the sample during the sample fixing, the EFMs were inserted into the gripping part of 
the probe together with aluminum foil (cut out before the measurements). The test speed was 0.04 
mm/s and the gripping distance was 40 mm. Each specimen was tested five times.  
 
2.9 Drug release  
The release behavior of CIP out of the EFMs was studied in PBS at pH 7.4. EFMs were cut into 
specific shape (5 cm × 4 cm), and placed in a centrifuge tube containing 10 mL of PBS. The tubes 
were shaking in a water bath at 100 rpm at 37 °C, and at designated time intervals (1, 2, 4, 8, 12, 
and 24 h followed by 2, 3, 4, 5, 6, 7, and 10 days, then afterwards every week until 14 weeks). 1 mL 
release medium was taken out and 1 mL fresh PBS was immediately added to maintain the volume. 
Each specimen was tested in triplicates, and the CIP concentration was measured by UV 
spectrophotometer (Evolution 300, Thermo Fisher Scientific, Waltham,  MA, USA) at 260 nm.  
 
2.10 Biodegradation behavior 
The biodegradation behavior of the EFMs were evaluated by measuring the weight change after 
incubating in PBS for a period of time. The initial mass of the samples were measured, and the 
samples were then degraded by placing them in PBS, pH 7.4 at 37 ºC. At selected time intervals (1, 
3, 5, 7, 9, 11, 13, and 15 weeks), the EFMs were removed from the solution, and the water on the 
surface was adsorbed by filter paper followed by drying the EFMs in a vacuum oven for 24 h, and 
then weighed. Each specimen was tested in triplicate. The biodegradation percentage, D (%), was 
defined as in Eq. 2:  
 
   D (%) = (wi – wt/wi) × 100%                                Eq. 2 
where wi is the initial weight of the sample and wt is the dried weight of the sample at the selected 
time intervals. 
  
 
 
2.11 Antimicrobial activity on solid culture medium  
Tryptic Soy Agar (TSA) was prepared by dissolving 40 g of dehydrated TSA medium in 1 L of 
purified, filtered water and sterilized at 121 °C for 15 min. Each agar plate was prepared by pouring 
10 mL of molten medium into a Petri dish (100 mm × 15 mm), and then the plate was allowed to 
solidify for 1 hour under sterile conditions in the laminar flow. Prior to use, bacteria from cryostock 
were grown overnight in Mueller-Hinton broth (MHB) at 37 °C. The overnight inoculum was 
transferred to fresh MHB and incubated for 2-3 h to reach exponential growth phase. Bacteria 
suspensions were adjusted to 0.5 McFarland suspension (1 x 10
8
 CFU/mL, optical density at 600 
nm (OD600) = 0.08-0.1) and further diluted 1:20 in MHB. A sterile inoculation loop was used to 
transfer bacteria from suspension to agar plates for contamination check every time bacteria were 
grown from cryostocks. 
For plating bacteria on the agar plates, 10 µL of adjusted bacteria suspension was added to 100 µL 
of MHB to yield 2-5 × 10
5
 CFU/mL. 100 µL of the suspension was then swabbed uniformly across 
the solid culture, then a round EFM (diameter, 10 mm) was placed on the surface of solid culture 
medium. Subsequently, the solid culture plates were cultivated in an INCUCELL incubator (MMM 
Medcenter Einrichtungen, München, Germany) at 37±2 °C for 20 h. The relative size of the 
inhibition zone was measured with calipers and recorded. All the samples were tested in triplicate. 
Broth micro dilution was used to determine the minimal inhibitory concentration (MIC) for 
S.aureus 15981 WT and CIP. Twofold dilutions of CIP in MHB (in the range 128 - 0.06 µg/ml) 
were prepared and 100 µL of each concentration was pipetted into a separate well of a sterile 
polystyrene flat-bottom 96-well plate (Costar Corning® 3596 cell culture plates, Corning, NY, 
USA). 10 µL of adjusted bacteria suspension was then added to yield 5 × 10
4
 CFU/well. For growth 
control, an antibiotic solution was replaced with MHB. 100 µL of MHB without bacteria was used 
as control of sterility. The broth dilution plates were incubated as described above. Visual turbidity 
or sedimentation was defined as bacterial growth, whereas lack of turbidity was considered as 
inhibition of growth. The lowest concentration of antibiotic that inhibited visual turbidity was 
defined as MIC value. 
 
2.12 Statistics 
The data are represented as means ± standard deviation (SD). Statistics were carried out using 
Origin software (v9.1, academic, OriginLab, Northampton, MA, USA). P-values below 5% (p < 
0.05) were considered statistically significant, unless otherwise stated. 
 
3. Results and discussion 
To accommodate both hydrophilic ALG and hydrophobic PLGA in the same EFM, ALG was first 
spray-dried into particles, and then suspended in PLGA solution. Subsequently, this suspension was 
processed using the elestrospinning process. It has been shown that co-axial electrospinning could 
be used to process two polymer solutions with different hydrophilicity properties into nanofibrous 
mats[26, 27]. However, maintaining the stability of the cone-jet in the co-axial electrospinning 
  
process is still a challenge due to distinct properties of the two polymer solutions, which may result 
in non-uniform fiber structure and defects in the mats[14, 28]. Another challenge is obtaining 
uniform distribution of the active drug compounds incorporated into the fibers. The drug molecules 
may migrate from one polymer to the other polymer matrix in the electropinning process[29], and 
the charge repulsion may lead to an enrichment of charged or polarizable agents on the surface of 
the fibers[30]. In contrast, electrospinning of heterogeneous systems such as suspension or emulsion 
using a single nozzle has been proven to be successful in terms of the stability of the 
electrospinning process and the formation of uniform fibers[31, 32]. In this study, a stable cone-jet 
of the ALG-PLGA suspension was obtained and the physicochemical properties of the resulting 
nanofibrous mats were characterized as described in the following sections[33]. 
 
3.1 SEM of the EFMs 
Spray dried ALG particles were spherical with a wide size distribution ranging from approximately 
100 nm to 15 µm (Fig. 1A). The particles were readily suspended in PLGA-trifluoroethanol 
solution prior to electrospinning. The EFMs exhibited a uniform diameter except that some beaded 
fibers were formed in the formulations with a relatively larger amount of spray-dried ALG particles 
(Fig. 1B-F). It can be explained by the fact that the size of some of the ALG particles was bigger 
than the diameter of the electrospun fibers. Nevertheless, stable cone-jets were observed at a voltage 
of approximately 9 kV for all the processings. The diameter of the resulting EFMs is showed in 
Table 1. The results showed that the diameter of EFMs was significantly decreased (p<0.05) with 
the modification of ALG particles compared to pure PLGA EFM. With addition of CIP, there was 
no significance change between pure PLGA EFM and CIP modified ALG/PLGA EFMs. 
 
 
 
Fig. 1 SEM images of the spray dried ALG particles and EFMs with and without ALG particles. 
A: spray dried ALG particles; B: PLGA EFM; C: PLGA-CIP EFM; D: 1% ALG/PLGA-CIP 
EFM; E: 2.5% ALG/PLGA-CIP EFM; F: 4% ALG/PLGA-CIP EFM.  
  
            Table 1. The diameter of EFMs with and without ALG particles. 
ALG/PLGA EFM ALG/PLGA-CIP EFM 
ALG 
(w/w, %) 
Diameter 
(mean ± SD, nm) 
ALG 
(w/w, %) 
Diameter 
(mean ± SD, nm) 
0 777 ± 249 0 821 ± 376 
1 673 ± 243* 1 877 ± 431 
2.5 633 ± 156* 2.5 749 ± 316 
4 676 ± 242* 4 747 ± 233 
                    Note: * p<0.05 compared with pure PLGA EFM  
3.2 Water contact angle of the EFMs  
Hydrophilicity is an important quality attribute for wound dressing as it influence cell viability and 
proliferation rate[34]. To evaluate the hydrophilicity of EFMs, water contact angles of the mats 
were measured. As expected, due to the hydrophilicity of ALG (water contact angle of 59º)[26], 
loading of ALG particles in the PLGA EFMs lowered the water contact angle as compared to the 
pure PLGA EFM, especially after 30 and 120 min (Fig. 2). It was found that from 0 % ALG to 1, 
2.5, and 4 % ALG, the water contact angle decreased from 111.7 ± 3.0° to 109.1 ± 2.6° to 103.6 ± 
1.1°, and to 97.3 ± 0.7°, respectively after 30 min. After 120 min, the water contact angles of these 
samples all were decreased to a value lower than 66°, close to the water contact angle of ALG. This 
observation indicates that ALG particles embedded in the PLGA EFMs can get wet by exposing the 
mats with water for longer time period. 
 
  
  
Fig.2 Water contact angle of EFMs without ALG particles, and with 1, 2.5 or 4% ALG particles. 
The contact angles were measured at 0, 30 and 120 min in triplicates, and the data shown are 
representative for the triplicates. 
 
3.3 Water uptake - swelling of the EFMs 
Water uptake is another critical quality attribute for a wound dressing as it reflects the dressing’s 
capacity to absorb drainage from open wounds. The presence of the hydrophilic polymer ALG 
obviously enhanced the absorption property to the mats. When incorporating ALG particles into the 
electrospun fibers, the EFMs absorbed 1.2 to 2.3 times more water than the PLGA EFM (Fig. 3). 
Especially the EFM loaded with 4% ALG particles showed a significant improvement of the water 
uptake capacity compared to the PLGA EFM (p = 0.012). The swelling capacity of the mats in this 
study was much lower than that of the pure ALG wound dressing (swelling capacity, 1 300 %) due 
to the limited amount of ALG used to modify the mats[35]. However, the ALG-modified PLGA 
EFMs reached the same swelling capacity as the one that was prepared from a hydrophilic polymer 
poly(vinyl alcohol), with the modification of ALG in the same amount[36].  
 
  
  
Fig.3 Swelling capacity of the EFMs with various ALG content ratios when immersed in PBS at 
pH 7.4 (mean±SD, n=3)., the * indicate significant difference for p < 0.05. 
 
3.4 Water sorption/desorption  
Beside the swelling ability of EFMs in PBS solution as aforementioned, the water-solid interactions 
of EFMs were analyzed by the water sorption/desorption analysis. The percentage of water vapor 
uptake with respect to the dry polymer weight at different RH is presented in Fig. 4. The EFMs with 
high amount of ALG particles showed higher water sorbing capacity as compared to the ones 
modified with relative lower amount of ALG, whereas the effect was negligible when the amount of 
ALG particles was 1% as compared to the one without modification of ALG.  
 
  
Fig.4 The water sorption/desorption profiles for EFMs without ALG particles, and with 1, 2.5 or 
4 % (w/w) ALG particles. The solid line and dotted line represent sorption and desorption 
process, respectively, and the data shown are representative for the triplicates. 
 
3.5 Drug release  
The release profiles of CIP from PLGA EFM and from ALG/PLGA EFMs were obtained in PBS at 
pH 7.4 (Fig. 6). For all the samples, a burst release can be observed in the first 7 days followed by a 
plateau stage with slow release of CIP continuing for up to 40 - 50 days. After the slow release 
phase and until the end of the study (between ca. 50 - 98 days), there was a fast release until a 
complete release of CIP from the EFMs. Wound healing is a lengthy process and normally takes 
between one month and several years, and an antimicrobial effect is necessary during the whole 
process, especially for the first 5 days after the injury[8]. The burst release can be attributed to the 
fast release of the CIP precipitated on the surface upon drying. The burst release appears increasing 
with an increase in ALG particles in the fibers, which may be attributed to improved hydrophilicity 
of the mats upon adding ALG and dissolution of ALG which generated larger surface area for drug 
diffusion. PLGA is a biodegradable polymer, which can undergo degradation (a decrease in average 
molecular weight) and subsequently erosion (a decrease in total mass) during the release study. 
When the polymer began to erode, more water could penetrate deep into the mats. Therefore, CIP 
was released faster, where both diffusion and polymer erosion contribute significantly to the drug 
release[37]. To further investigate the release mechanism of the mats, the degradation rate of PLGA 
was measured and is described in the next section.  
 
  
Fig.5 Cumulative release of CIP from PLGA or ALG/PLGA EFMs (containing 1, 2.5 or 4 % 
ALG) in PBS, pH 7.4 at 37°C over a period of 98 days (mean±SD, n=3).  
  
 
3.6 Biodegradation rate of PLGA  
The biodegradation rate of polymer is important for a drug delivery system and is strongly related to 
the drug release profile. PLGA is known to degrade upon hydrolysis. The percentage of weight loss 
of PLGA and ALG/PLGA EFMs was studied and the results shown in Fig. 6. For all EFMs, the 
weight loss increased over time, but was slow in the first 50 - 80 days. The result was similar to that 
found in a previous study, where the PLGA with higher molecular weight did not show any 
detectable change in the degradation until 53 days[38]. After the slow degradation phase, the 4 % 
ALG/PLGA EFM began to have a fast weight loss from day 50, while the other EFMs started to 
degrade faster after 80 days. Generally, the EFMs with higher amounts of ALG particles degraded 
faster, which can probably be explained by the swelling and dissolution of ALG, which results in 
pores in the matrix. This resulted in increased contact between PLGA and the PBS medium, and 
thereby accelerateed the hydrolysis of the PLGA. The difference in the degradation rates between 
different EFMs became noticeable after 80 days of incubation, and after 105 days of incubation the 
EFMs disintegrated into small pieces.  
     
Fig. 6 Degradation of PLGA and PLGA/ALG (with 1, 2.5, 4 % ALG) EFMs in PBS, pH 7.4 at 
37ºC for a period of 105 days. (mean±SD, n=3).  
 
3.7 Mechanical properties of the EFMs 
The mechanical properties of EFMs used as wound dressing are important as it is supposed to serve 
as a mechanical barrier or to provide physical support for cell growth and migration[34]. The result 
in Fig. 7 presents the typical stress-strain curves of the EFMs, where the Young’s modulus of the 
EFMs describes stiffness (Fig. 8). Compared with the PLGA electrospun EFM, both the tensile 
  
strength and elongation rate of EFMs containing either ALG particles or CIP decreased 
dramatically. However, the Young’s modulus and tensile strength of human skin are around 6070 
MPa and 1721 MPa, respectively [39, 40]. Therefore, after blending with ALG particles or CIP, 
the tensile strength of EFM was much lower than that of human skin, but the Young’s modulus was 
more close to human skin. During the wound healing period, the temporary protection at the injury 
site after epithelialization is only 15 % tensile strength of the original skin, therefore it can be 
concluded that the electrospun CIP-ALG/PLGA EFMs are strong enough to protect the injury site. 
   
Fig. 7 Tensile strength of PLGA/ALG EFMs loaded/unloaded with CIP. A: PLGA EFM 
with/without ALG particles (1, 2.5 and 4 %); B: CIP-loaded PLGA EFM with/without ALG (1, 
2.5 and 4 %) particles (three replicate measurements). 
  
Fig.8 Young’s modulus of the EFMs loaded/non-loaded with CIP (mean±SD, n=3).  
 
  
3.8 Antimicrobial activity in solid culture medium  
The MIC for ciprofloxacin and S. aureus 15981 WT was determined to be 0.125 µg/mL using the 
broth microdilution method, which was reached at the very beginning (within the first 15 min) of 
the release study. The PLGA EFM did not show any antimicrobial activity, while all the CIP-loaded 
EFMs (drug loading, 1 %, w/w) exhibited an inhibition zone ranging from 3545 mm (Fig. 10). All 
EFMs containing ALG showed an inhibition zone equal to or larger than PLGA-CIP EFM 
indicating that the antimicrobial activity was not compromised by the addition of the ALG particles. 
The EFM containing 4 % ALG showed the best antimicrobial activity, and a significant 
improvement was found compared to CIP-PLGA EFM (p = 0.03). This can probably be explained 
by a higher amount of CIP released from the 4 % ALG EFM compared to the other formulations 
within the studied time period of 24 h. All the CIP-loaded EFMs showed good antibacterial effect, 
since the diameter of inhibition zone was larger than 21 mm[41]. 
  
Fig. 10 The average diameter of the bacteria inhibition zone for CIP-loaded PLGA or 
ALG/PLGA EFMs within the time period of 24 h(mean±SD, n=3).  
 
4. Conclusion 
In this study, antibiotic-loaded electrospun hydrophobic polymer (PLGA) fibrous mats modified 
with hydrophilic polymer (soldium alginate) were prepared for wound healing purpose. The 
addition of hydrophilic polymer improved the wettability, water uptake potential of the hydrophobic 
mats and facilitated the release of the antibiotic at the early diffusion phase. Moreover, the resulting 
polymeric fibrous mats exhibited sufficient mechanical support for injure area. This study 
demonstrated the feasibility of incorporating a hydrophilic natural polymer into a hydrophobic 
synthetic polymer matrix by the electrospinning process to produce a promising wound dressing 
material. 
Acknowledgement 
  
This study was supported, in part, by Graduate School of Health and Medical Sciences of 
University of Copenhagen, Department of Pharmacy of University of Copenhagen, Department of 
Chemical Engineering, Biotechnology and Environmental Technology, University of Southern 
Denmark, the Danish Council for Independent Research, Technology and Production Sciences (FTP, 
Project 12-126515/0602-02670B), and University of Copenhagen Research Centre for Control of 
Antibiotic Resistance (UC-CARE). Furthermore, Line Hagner Nielsen would like to thank the 
Danish Research Council for Technology and Production (FTP), Project DFF-4004-00120B for 
financial support, and in addition, the Denmarks Grundforskningsfonds (project DNRF122) and 
Villum Fondens Center for Intelligent Drug Delivery and Sensing Using Microcontainers and 
Nanomechanics (IDUN) is acknowledged. 
 
Reference 
[1] S. Enoch, D.J. Leaper, Basic science of wound healing, Surgery (Oxford), 26 (2008) 31-37. 
[2] G.C. Gurtner, S. Werner, Y. Barrandon, M.T. Longaker, Wound repair and regeneration, Nature, 
453 (2008) 314-321. 
[3] K. Moore, R. McCallion, R.J. Searle, M.C. Stacey, K.G. Harding, Prediction and monitoring the 
therapeutic response of chronic dermal wounds, Int Wound J, 3 (2006) 89-98. 
[4] K. Cutting, R.J. White, Maceration of the skin and wound bed I: its nature and causes, J Wound 
care, 11 (2002) 275-278. 
[5] K. Vowden, P. Vowden, Wound dressings: principles and practice, Surgery (Oxford), 32 (2014) 
462-467. 
[6] P.S. Murphy, G.R. Evans, Advances in wound healing: a review of current wound healing 
products, Plast Surg Int, 2012 (2012) 1-8. 
[7] L.I. Moura, A.M. Dias, E. Carvalho, H.C. de Sousa, Recent advances on the development of 
wound dressings for diabetic foot ulcer treatment--a review, Acta Biomater, 9 (2013) 7093-7114. 
[8] J.R. Davidson, Current concepts in wound management and wound healing products, Vet Clin 
North Am Small Anim Pract, 45 (2015) 537-564. 
[9] S. Seaman, Dressing selection in chronic wound management, J Am Podiatr Med Assoc, 92 
(2002) 24-33. 
[10] C. McIntosh, Are hydrocolloid dressings suitable for diabetic foot ulcers?, Wounds Essentials 
(2007) 170-172. 
[11] M.A. Fonder, G.S. Lazarus, D.A. Cowan, B. Aronson-Cook, A.R. Kohli, A.J. Mamelak, 
Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care 
dressings, J Am Acad Dermatol, 58 (2008) 185-206. 
[12] J. Boateng, O. Catanzano, Advanced Therapeutic Dressings for Effective Wound Healing--A 
Review, J Pharm Sci, 104 (2015) 3653-3680. 
[13] X. Zhu, W. Cui, X. Li, Y. Jin, Electrospun fibrous mats with high porosity as potential 
scaffolds for skin tissue engineering, Biomacromolecules, 9 (2008) 1795-1801. 
[14] K.A. Rieger, N.P. Birch, J.D. Schiffman, Designing electrospun nanofiber mats to promote 
wound healing – a review, J Mater Chem B, 1 (2013) 4531-4541. 
[15] W.J. Li, C.T. Laurencin, E.J. Caterson, R.S. Tuan, F.K. Ko, Electrospun nanofibrous structure: 
a novel scaffold for tissue engineering, J Biomed Mater Res, 60 (2002) 613-621. 
[16] R. Jayakumar, M. Prabaharan, P.S. Kumar, S. Nair, H. Tamura, Biomaterials based on chitin 
and chitosan in wound dressing applications, Biotechnol Adv, 29 (2011) 322-337. 
  
[17] B.-M. Min, G. Lee, S.H. Kim, Y.S. Nam, T.S. Lee, W.H. Park, Electrospinning of silk fibroin 
nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and 
fibroblasts in vitro, Biomaterials, 25 (2004) 1289-1297. 
[18] K.S. Rho, L. Jeong, G. Lee, B.-M. Seo, Y.J. Park, S.-D. Hong, S. Roh, J.J. Cho, W.H. Park, B.-
M. Min, Electrospinning of collagen nanofibers: effects on the behavior of normal human 
keratinocytes and early-stage wound healing, Biomaterials, 27 (2006) 1452-1461. 
[19] J.A. Matthews, G.E. Wnek, D.G. Simpson, G.L. Bowlin, Electrospinning of collagen 
nanofibers, Biomacromolecules, 3 (2002) 232-238. 
[20] T. Freyman, I. Yannas, L. Gibson, Cellular materials as porous scaffolds for tissue engineering, 
Prog Mater Sci, 46 (2001) 273-282. 
[21] D. Kai, S.S. Liow, X.J. Loh, Biodegradable polymers for electrospinning: towards biomedical 
applications, Mater Sci Eng C Mater Biol Appl, 45 (2014) 659-670. 
[22] A.L.R. Pires, Â.M. Moraes, Improvement of the mechanical properties of chitosan‐alginate 
wound dressings containing silver through the addition of a biocompatible silicone rubber, J Appl 
Polym Sci, 132 (2015), 41686 (1-9). 
[23] N. Bhardwaj, S.C. Kundu, Electrospinning: a fascinating fiber fabrication technique, 
Biotechnol Adv, 28 (2010) 325-347. 
[24] G.D. Mogosanu, A.M. Grumezescu, Natural and synthetic polymers for wounds and burns 
dressing, Int J Pharm, 463 (2014) 127-136. 
[25] X. Liu, S.G. Baldursdottir, J. Aho, H. Qu, L.P. Christensen, J. Rantanen, M. Yang, 
Electrospinnability of Poly Lactic-co-glycolic Acid (PLGA): the Role of Solvent Type and Solvent 
Composition, Pharm Res, (2017) 1-12. 
[26] M.A. de Moraes, A.C. Rodas, O.Z. Higa, M.M. Beppu, Membranes of biopolymer blends for 
wound healing applications. The 6th Latin American Congress of Artifical Organs and Biomaterials  
[27] S. Sahoo, S.L. Toh, J.C. Goh, A bFGF-releasing silk/PLGA-based biohybrid scaffold for 
ligament/tendon tissue engineering using mesenchymal progenitor cells, Biomaterials, 31 (2010) 
2990-2998. 
[28] F. Li, X.Y. Yin, X.Z. Yin, Instability of a leaky dielectric coaxial jet in both axial and radial 
electric fields, Phys Rev E Stat Nonlin Soft Matter Phys, 78 (2008) 036302 (1-11). 
[29] X. Huang, C.S. Brazel, On the importance and mechanisms of burst release in matrix-
controlled drug delivery systems, J Control Release, 73 (2001) 121-136. 
[30] X.Y. Sun, L.R. Nobles, H.G. Börner, R.J. Spontak, Field‐Driven Surface Segregation of 
Biofunctional Species on Electrospun PMMA/PEO Microfibers, Macromol Rapid Commun, 29 
(2008) 1455-1460. 
[31] J. Gunn, M. Zhang, Polyblend nanofibers for biomedical applications: perspectives and 
challenges, Trends Biotechnol, 28 (2010) 189-197. 
[32] M.V. Jose, V. Thomas, K.T. Johnson, D.R. Dean, E. Nyairo, Aligned PLGA/HA nanofibrous 
nanocomposite scaffolds for bone tissue engineering, Acta Biomater, 5 (2009) 305-315. 
[33] L.R. Lakshman, K.T. Shalumon, S.V. Nair, R. Jayakumar, S.V. Nair, Preparation of Silver 
Nanoparticles Incorporated Electrospun Polyurethane Nano-fibrous Mat for Wound Dressing, J 
Macromol Sci, Part A, 47 (2010) 1012-1018. 
[34] M. Prabaharan, R. Jayakumar, S. Nair, Biomedical applications of polymeric nanofibers[M], , 
Springer Science & Business Media, 2012. 
[35] D. Parikh, J. Edwards, B. Condon, A. Parikh, Silver-Carboxylate Ion-Paired Alginate and 
Carboxymethylated Cotton with Antimicrobial Activity, AATCC review, 8 (2008) 38-43. 
[36] R. Fu, C. Li, C. Yu, H. Xie, S. Shi, Z. Li, Q. Wang, L. Lu, A novel electrospun membrane 
based on moxifloxacin hydrochloride/poly (vinyl alcohol)/sodium alginate for antibacterial wound 
dressings in practical application, Drug Deliv, (2014) 1-12. 
  
[37] A. Szentivanyi, T. Chakradeo, H. Zernetsch, B. Glasmacher, Electrospun cellular 
microenvironments: Understanding controlled release and scaffold structure, Adv Drug Deliv Rev, 
63 (2011) 209-220. 
[38] T.G. Park, Degradation of poly (D, L-lactic acid) microspheres: effect of molecular weight, J 
Control Release, 30 (1994) 161-173. 
[39] A. Gallagher, A. Ní Annaidh, K. Bruyère, Dynamic tensile properties of human skin, in: 
IRCOBI Conference, 12-14 September 2012, Dublin (Ireland). 
[40] M. Pawlaczyk, M. Lelonkiewicz, M. Wieczorowski, Age-dependent biomechanical properties 
of the skin, Postepy Dermatol Alergol, 30 (2013) 302-306. 
[41] S.Q. Ali, A. Zehra, B.S. Naqvi, S. Shah, R. Bushra, Resistance pattern of ciprofloxacin against 
different pathogens, Oman Med J, 25 (2010) 294-298. 
 
 
  
 
